Article

Dr. Susan Urba Discusses Cost Concerns for Treatment of Chemotherapy-Induced Nausea

In this segment, Dr. Susan Urba, University of Michigan, Comprehensive Cancer Center, talks about treatment guidelines and decisions relevant to chemotherapy-induced nausea and vomiting (CINV) in a managed care setting.

In addition, Dr. Urba warns of the consequences associated with the treatment of CINV when cost concerns impact best practices. Often, these consequences can include increased costs from uncontrolled symptoms and potential hospital admission due to dehydration.

Related Videos
ATS 2025
Bridgette J. Picou, LVN, ACLPN, The Well Project
John Barkett, MBA
Dr Gerard Criner
Emma Achola-Kothari, PhD
Dr Margrit Wiesendanger
Dr Emma Achola-Kothani
Marla Black Morgan, MD, Phoebe Neurology Associates
Christine Funke, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo